Elizabeth A. Barrett

UroGen Pharma Ltd.

Elizabeth Barrett brings to her CEO post at UroGen extensive experience leading business organizations and Fortune 500 pharmaceutical companies. Prior to UroGen, Liz was CEO of Novartis Oncology and a member of the Novartis Executive Committee. She previously served as global president of Oncology at Pfizer Inc., where she held numerous leadership positions, including president of Global Innovative Pharma for Europe, [resident of the Specialty Care Business Unit for North America, and president of United States Oncology. Earlier in her career, Liz held positions at Cephalon Inc., where she was vice president and general manager of the Oncology Business Unit, and vice president at Johnson & Johnson. She has been the recipient of numerous awards including DTC Marketer of the Year, Women’s Leadership Initiative Ambassador and VP/Sales Marketing Award. Liz holds an MBA from Saint Joseph’s University and a BS from the University of Louisiana.

Year appointed: 2019